Startup Aims to Produce 10,000 COVID-19 Kits a Day at Los Angeles Lab

Startup Aims to Produce 10,000 COVID-19 Kits a Day at Los Angeles Lab

At a 10,000 square foot San Dimas lab, Fred Turner is furiously trying to save people from COVID-19.

The head of a Bay Area startup known as Curative Inc. arrived in Los Angeles Wednesday, on a near empty flight, as he launched a production facility to produce coronavirus testing kits. They'll be deployed to drive-thru testing centers across the United States, which National Institute of Allergy and Infectious Diseases Director Anthony Fauci said was severely lagging other countries in determining how widespread the virus is.

Turner's startup is "aiming to add 10,000 test per day capacity in about two weeks," he said. "We can now do 50 a day, by Monday 150, and the end of the week 1,000 a day."


Los Angeles County, home to more than 10 million people, has suffered like other parts of the country with a shortage of tests. So far, county officials said about 250 people have been tested as of March 11. Stories abound of sick patients who want to see if they have COVID-19 but can't because there's a shortage of kits and labs that can analyze them.

In Denver, one city that has set up drive-thru testing centers, there are reports of four-hour waits.

"We thought the big testing labs would have it under control, but it became apparent to us that there wasn't enough testing," he said. Turner, whose company normally works on trying to prevent deaths due to sepsis, said his team was working on scaling up a manual testing process often used in research and development labs to create kits.

Unlike other labs which rely on off-the shelf testing kits and automated machines, Turner will use a process that requires more steps to extract information from RNA to determine whether or not somebody has the virus.

He was helped earlier this month by federal officials who issued emergency authorization for labs to develop tests.

Turner said his tests will provide results within 24 hours and eliminate unnecessary risk to health care workers by using saliva samples taken from a swab, rather than nasal ones which require a nurse. "The largest deficit right now is not screening health care workers," he said. "That's just unacceptable."

On Wednesday, the union representing California nurses staged protests around the state calling for more stringent workplace safety guidelines than those provided by Center for Disease Control, which it says leaves them at risk for contracting the virus.

Working with Bay Area startup 650Health, along with another company, Turner aims to get the tests distributed at drive-thru clinics, at homes, and through employers.

Subscribe to our newsletter to catch every headline.

TikTok competitor Triller is in advanced talks with at least three blank-check companies to go public at a valuation between $3 billion and $6 billion, according to sources familiar with the matter.

That range is broad because the L.A.-based viral video app is seeking to acquire one of its strategic partners, a U.S. subsidiary of a foreign-listed company, before merging with a special purpose acquisition company or SPAC, those sources said. The target company is a tech business that Triller already works with to help monetize its app. If that acquisition goes through, one source said, Triller's revenues would increase from around $100 million to $300 million, and its valuation could be on the higher end of the reported range.

Read more Show less

Fred Turner, the 25-year-old founder of Curative Inc., is the man behind L.A.'s push to bring universal testing to the region. But, he has bigger plans.

Turner, an Oxford dropout, just landed a deal with the Air Force to test military worldwide and he's now eyeing national expansion for his startup. By the end of this month, the company he started months ago is expected to pump out more than a million test kits a week.

"We are a strange company because our goal is to essentially put ourselves out of business," Turner said.

Read more Show less
RELATEDTRENDING